Advisory Board
Scientific Advisory Board
The Scientific Advisory Board consists of leading scientists in the fields of research into the aging process and research on age-related diseases, such as Alzheimer's disease and cancer. Members provide guidance on the Institute's scientific and educational programs.
Members of the 2008 Scientific Advisory Board
 |
Charles J. Epstein, MD, Chair Professor of Pediatrics, Emeritus Chief, Division of Medical Genetics Co-Director, UCSF Program in Human Genetics Area of Interest: Comparative Genetics |
 |
Leonard P. Guarente, PhD Professor of Biology, Massachusetts Institute of Technology Area of Interest: Aging Genes in Yeast |
 |
Stephen L. Hauser, MD Chairman and Robert A. Fishman Distinguished Professor Department of Neurology University of California, San Francisco Area of Interest: Multiple Sclerosis |
 |
Cynthia J. Kenyon, PhD American Cancer Society Professor Director, Hillblom Center for the Biology of Aging Professor, Department of Biochemistry & Biophysics University of California, San Francisco Area of Interest: Genetics, Mechanism of Aging |
 |
Stuart Kim, PhD Professor, Department of Developmental Biology Stanford University Medical Center Area of Interest: Molecular Biology |
 |
Mary F. Lopez, PhD Director BRIMS (Biomarker Research Initiatives in MS) Thermo Fisher Scientific Area of Interest: Proteom i cs |
 |
Bruce L. Miller, MD A.W. & Mary-Margaret Clausen Professor of Neurology University of California, San Francisco Area of Interest: Dementia |
 |
Lennart Mucke, MD Director, Gladstone Institute of Neurological Disease J. David Gladstone Institutes Professor of Neurology University of California, San Francisco Area of Interest: Alzheimer's Disease |
 |
Linda Partridge, PhD Weldon Professor of Biometry Centre for Research into Ageing Dept. of Biology, University College, London Area of Interest: Aging Research |
 |
Brian Shoichet, PhD Professor of Pharmaceutical Chemistry Department of Biopharmaceutical Sciences University of California, San Francisco Area of Interest: Structure-based inhibitor discovery |
